Continuing to advance
science for patient care

Pipeline medicines in development

Our pipeline isn’t just about what’s next in medicine—it’s about getting there faster. From novel immunotherapies to high-impact biosimilars, we’re building treatments that not only push science forward, but also bring it within reach for more patients. That’s why we’re developing next-generation antibodies, antibody-drug conjugates, biosimilars, and more—innovations that bring new hope to those facing cancer, autoimmune diseases, and other conditions.